<DOC>
	<DOCNO>NCT01611974</DOCNO>
	<brief_summary>This study ass safety , antiviral activity , pharmacokinetics different dos maribavir administer orally 24 week treatment CMV infection resistant refractory treatment ganciclovir/valganciclovir foscarnet recipient stem cell solid organ transplant .</brief_summary>
	<brief_title>Maribavir Treatment Resistant Refractory CMV Infections Transplant Recipients</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Cytomegalovirus Infections</mesh_term>
	<criteria>Inclusion Criteria 1 . Be ≥12 year age . 2 . Weigh ≥ 40 kg . 3 . Be recipient stem cell solid organ transplantation . 4 . Have document CMV infection blood plasma , screen value ≥1,000 DNA copies/mL . 5 . Have current CMV infection resistant ( know CMV genetic mutation ) refractory ( clinical failure respond ) treatment ganciclovir/valganciclovir and/or foscarnet . 6 . If female , either postmenopausal , surgically sterile , negative pregnancy test prior randomization . 7 . Be able swallow tablet . 8 . If adult , provide write informed consent . If child ( age &lt; 18 year ) , parent/legal guardian willing able provide write informed consent ( assent child appropriate ) . 9 . Be assess investigator determine whether prophylaxis nonCMV herpesvirus infection ( e.g. , herpes simplex virus [ HSV type 1 type 2 ] varicella zoster virus [ VZV ] ) appropriate accord institutional guideline standard practice , keep mind maribavir active vitro virus . Exclusion Criteria 1 . Be receive antiCMV agent ( ) . 2 . Have current CMV infection consider resistant refractory due inadequate adherence prior oral antiCMV treatment . 3 . Have severe vomiting , diarrhea , severe gastrointestinal illness within 24 hour prior time enrollment . 4 . Have severe hepatic impairment . 5 . Require mechanical ventilation vasopressor hemodynamic support time enrollment . 6 . Have expect survival le 6 week . 7 . Be pregnant breastfeeding . 8 . Other clinically significant medical surgical condition .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>CMV</keyword>
	<keyword>cytomegalovirus</keyword>
	<keyword>resistant</keyword>
	<keyword>refractory</keyword>
	<keyword>transplant</keyword>
	<keyword>treatment</keyword>
</DOC>